MX2007008980A - Acidos nucleicos para apoptosis de celulas cancerigenas. - Google Patents
Acidos nucleicos para apoptosis de celulas cancerigenas.Info
- Publication number
- MX2007008980A MX2007008980A MX2007008980A MX2007008980A MX2007008980A MX 2007008980 A MX2007008980 A MX 2007008980A MX 2007008980 A MX2007008980 A MX 2007008980A MX 2007008980 A MX2007008980 A MX 2007008980A MX 2007008980 A MX2007008980 A MX 2007008980A
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- apoptosis
- nucleic acids
- cancer cells
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invencion se refiere a un acido nucleico que tiene una Secuencia Apoptotica de la Sec. ID. No. 1, Sec. ID. No. 2, Sec. ID. No. 3, Sec. ID. No. 4, Sec. ID. No. 5, Sec. ID. No. 6 y Sec. ID. No. 7. Tambien se refiere a una composicion que incluye un acido nucleico que tiene una Secuencia Apoptotica de la Sec. ID. No. 1, Sec. ID. No. 2, Sec. ID. No. 3, Sec. ID. No. 4, Sec. ID. No. 5, Sec. ID. No. 6 y Sec. ID. No. 7. La composicion tambien puede incluir un portador farmaceuticamente aceptable. La descripcion tambien incluye un metodo para eliminar una celula cancerigena administrando a una celula cancerigena, un suero que incluye un acido nucleico que tiene una Secuencia Apoptotica de la Sec. ID. No. 1, Sec. ID. No. 2, Sec. ID. No. 3, Sec. ID. No. 4, Sec. ID. No. 5, Sec. ID. No. 6 y Sec. ID. No. 7 y un portador farmaceuticamente aceptable. El portador puede ser localizado en un sujeto con cancer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64696105P | 2005-01-25 | 2005-01-25 | |
US66963905P | 2005-04-08 | 2005-04-08 | |
PCT/US2005/045903 WO2006081008A2 (en) | 2005-01-25 | 2005-12-19 | Nucleic acids for apoptosis of cancer cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007008980A true MX2007008980A (es) | 2008-01-14 |
Family
ID=36740938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007008980A MX2007008980A (es) | 2005-01-25 | 2005-12-19 | Acidos nucleicos para apoptosis de celulas cancerigenas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060194229A1 (es) |
EP (1) | EP1841866B1 (es) |
JP (1) | JP2008527996A (es) |
KR (1) | KR20070095452A (es) |
AT (1) | ATE429495T1 (es) |
AU (1) | AU2005325716A1 (es) |
CA (1) | CA2592562A1 (es) |
DE (1) | DE602005014148D1 (es) |
MX (1) | MX2007008980A (es) |
WO (1) | WO2006081008A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007121054A2 (en) * | 2006-03-27 | 2007-10-25 | Sky Genetics, Inc. | Nucleic acids for apoptosis of cancer cells |
US8822153B2 (en) * | 2007-06-01 | 2014-09-02 | The University Of North Carolina At Chapel Hill | Molecular diagnosis and typing of lung cancer variants |
WO2009131366A2 (ko) * | 2008-04-21 | 2009-10-29 | 한국생명공학연구원 | 위암 또는 대장암 진단 마커 및 치료제로서의 cdca5 |
KR101166256B1 (ko) * | 2008-04-21 | 2012-07-18 | 한국생명공학연구원 | 위암 또는 대장암 진단 마커 및 치료제로서의 cdca5 |
CA2740046A1 (en) * | 2008-10-09 | 2010-04-15 | British Columbia Cancer Agency Branch | Detection of granulosa-cell tumors |
WO2010042228A2 (en) * | 2008-10-10 | 2010-04-15 | Cornell University | Methods for predicting disease outcome in patients with colon cancer |
ES2700098T3 (es) * | 2009-05-15 | 2019-02-14 | Insight Genetics Inc | Métodos relacionados con las fusiones de ALK para diagnosticar el cáncer |
KR101441013B1 (ko) * | 2011-06-30 | 2014-09-18 | 충남대학교산학협력단 | 유방암 진단용 바이오마커 |
BR112017006419A2 (pt) | 2014-09-30 | 2017-12-19 | Univ Washington | medições cinéticas de tau |
CN110331201B (zh) * | 2019-07-26 | 2022-04-08 | 泗水县人民医院 | 宫颈鳞癌相关生物标志物及其应用 |
CN110904214B (zh) * | 2019-12-13 | 2020-12-15 | 四川省人民医院 | 用于诊断或辅助诊断肾功能不全或肾损伤的诊断剂、试剂盒和应用 |
CN111118164A (zh) * | 2020-03-02 | 2020-05-08 | 遵义市第一人民医院 | 一种用于肿瘤早期筛查和诊断的标志物、试剂盒及检测方法 |
CN111751529A (zh) * | 2020-05-12 | 2020-10-09 | 陕西中医药大学 | 一种抽动障碍的血清多肽标志物p及其检测方法 |
CN116482367A (zh) * | 2023-05-04 | 2023-07-25 | 中国中医科学院望京医院(中国中医科学院骨伤科研究所) | 一种联合mSEPT9检测和生物标志物的结直肠癌检测方法 |
CN117051112B (zh) * | 2023-10-12 | 2023-12-29 | 上海爱谱蒂康生物科技有限公司 | 生物标志物组合在制备预测淋巴瘤的试剂盒中的应用 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4475196A (en) * | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
US4447233A (en) * | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
US4439196A (en) * | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
US4447224A (en) * | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
US4487603A (en) * | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
US4486194A (en) * | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
US4596556A (en) * | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
US4790824A (en) * | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US4941880A (en) * | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5424186A (en) * | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5527681A (en) * | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US6416952B1 (en) * | 1989-06-07 | 2002-07-09 | Affymetrix, Inc. | Photolithographic and other means for manufacturing arrays |
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US6346413B1 (en) * | 1989-06-07 | 2002-02-12 | Affymetrix, Inc. | Polymer arrays |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5064413A (en) * | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5312335A (en) * | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US6506558B1 (en) * | 1990-03-07 | 2003-01-14 | Affymetrix Inc. | Very large scale immobilized polymer synthesis |
US5386023A (en) * | 1990-07-27 | 1995-01-31 | Isis Pharmaceuticals | Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
DE69132905T2 (de) * | 1990-12-06 | 2002-08-01 | Affymetrix Inc N D Ges D Staat | Detektion von Nukleinsäuresequenzen |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US5383851A (en) * | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
US5837832A (en) * | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US6027880A (en) * | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
US5861242A (en) * | 1993-06-25 | 1999-01-19 | Affymetrix, Inc. | Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same |
US5624803A (en) * | 1993-10-14 | 1997-04-29 | The Regents Of The University Of California | In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom |
US6156501A (en) * | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US5429807A (en) * | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
AU2360195A (en) * | 1994-05-05 | 1995-11-29 | Beckman Instruments, Inc. | Oligonucleotide repeat arrays |
US5556752A (en) * | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US6239273B1 (en) * | 1995-02-27 | 2001-05-29 | Affymetrix, Inc. | Printing molecular library arrays |
US5624711A (en) * | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US6022963A (en) * | 1995-12-15 | 2000-02-08 | Affymetrix, Inc. | Synthesis of oligonucleotide arrays using photocleavable protecting groups |
US6013440A (en) * | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
US6255071B1 (en) * | 1996-09-20 | 2001-07-03 | Cold Spring Harbor Laboratory | Mammalian viral vectors and their uses |
US6025192A (en) * | 1996-09-20 | 2000-02-15 | Cold Spring Harbor Laboratory | Modified retroviral vectors |
WO1998020967A1 (en) * | 1996-11-14 | 1998-05-22 | Affymetrix, Inc. | Chemical amplification for the synthesis of patterned arrays |
US6887665B2 (en) * | 1996-11-14 | 2005-05-03 | Affymetrix, Inc. | Methods of array synthesis |
US6833450B1 (en) * | 2000-03-17 | 2004-12-21 | Affymetrix, Inc. | Phosphite ester oxidation in nucleic acid array preparation |
US6806361B1 (en) * | 2000-03-17 | 2004-10-19 | Affymetrix, Inc. | Methods of enhancing functional performance of nucleic acid arrays |
US6949638B2 (en) * | 2001-01-29 | 2005-09-27 | Affymetrix, Inc. | Photolithographic method and system for efficient mask usage in manufacturing DNA arrays |
WO2005054517A2 (en) * | 2003-12-01 | 2005-06-16 | Epigenomics Ag | Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
US20080026410A1 (en) * | 2004-12-02 | 2008-01-31 | Antonia Vlahou | Biomarkers for Bladder Cancer |
US20060183893A1 (en) * | 2005-01-25 | 2006-08-17 | North Don A | Nucleic acids for apoptosis of cancer cells |
-
2005
- 2005-12-19 MX MX2007008980A patent/MX2007008980A/es not_active Application Discontinuation
- 2005-12-19 AT AT05854583T patent/ATE429495T1/de not_active IP Right Cessation
- 2005-12-19 DE DE200560014148 patent/DE602005014148D1/de not_active Expired - Fee Related
- 2005-12-19 KR KR20077019450A patent/KR20070095452A/ko not_active Application Discontinuation
- 2005-12-19 CA CA 2592562 patent/CA2592562A1/en not_active Abandoned
- 2005-12-19 JP JP2007552135A patent/JP2008527996A/ja active Pending
- 2005-12-19 AU AU2005325716A patent/AU2005325716A1/en not_active Abandoned
- 2005-12-19 WO PCT/US2005/045903 patent/WO2006081008A2/en active Application Filing
- 2005-12-19 EP EP20050854583 patent/EP1841866B1/en not_active Not-in-force
-
2006
- 2006-01-24 US US11/339,052 patent/US20060194229A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060194229A1 (en) | 2006-08-31 |
DE602005014148D1 (de) | 2009-06-04 |
CA2592562A1 (en) | 2006-08-03 |
EP1841866B1 (en) | 2009-04-22 |
EP1841866A2 (en) | 2007-10-10 |
AU2005325716A1 (en) | 2006-08-03 |
WO2006081008A3 (en) | 2006-12-14 |
ATE429495T1 (de) | 2009-05-15 |
KR20070095452A (ko) | 2007-09-28 |
WO2006081008A2 (en) | 2006-08-03 |
JP2008527996A (ja) | 2008-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008980A (es) | Acidos nucleicos para apoptosis de celulas cancerigenas. | |
MX2008007286A (es) | Ingenieria in vivo de superficie celular. | |
WO2006018836A3 (en) | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues | |
IL213613A (en) | History of pirazine, preparations containing them and their uses | |
WO2010048552A3 (en) | Methods of using oligomeric compounds comprising 2'-substituted nucleosides | |
YU44404A (sh) | Postupak za identifikovanje ciljnih enzima tumora | |
EA201070030A1 (ru) | Синтез и применение антиинвертированных фосфоротиоатных аналогов кэп-структуры матричной phk | |
CN101687915B8 (zh) | 跨物种特异性CD3-ε结合结构域 | |
IL144703A0 (en) | Methods and reagents for treating glucose metabolic disorders | |
EP1483281A4 (en) | METHOD FOR THE PRODUCTION OF INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC APPLICATIONS OF SUCH MOLECULES | |
UA92157C2 (ru) | Способ продуцирования гормона роста | |
WO2006017134A3 (en) | Preprimitive streak and mesendoderm cells | |
NZ584893A (en) | PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF | |
WO2006116181A3 (en) | Regulatory t cell mediator proteins and uses thereof | |
WO2008070666A3 (en) | Compositions and methods to treat cancer with cpg rich dna and cupredoxins | |
WO2009151907A3 (en) | Compositions and methods for using cells to treat heart tissue | |
WO2008042686A3 (en) | Multifunctional carriers for the delivery of nucleic acids and methods of use thereof | |
WO2006010070A3 (en) | Compositions and methods related to peptides that selectively bind leukemia cells | |
WO2006065894A3 (en) | Methods for inhibiting stat3 signaling in immune cells | |
WO2006097743A3 (en) | Method for actvating natural killer cells by tumor cell preparation in vitro | |
MX2009002787A (es) | Composiciones y métodos para prevenir el cáncer con cupredoxinas. | |
WO2004062602A3 (en) | Compositions and methods for targeted biological delivery of molecular carriers | |
SG10201407944TA (en) | Imp-3 oligopeptides and vaccines including the same | |
WO2005120588A3 (en) | Peptides delivered to cell nuclei | |
WO2003070905A3 (en) | Electroporation methods for introducing bioactive agents into cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |